GO:0050792 regulation of viral process: Host-Virus Interaction Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050792 regulation of viral process describes any host or viral activity that modulates the rate or extent of the viral life cycle, from entry to spread.
• Viral miRNAs are a major class of viral regulators that fine-tune host gene expression to favor replication and immune evasion.
• Epigenetic and epitranscriptomic modifications, including m6A RNA methylation and histone acetylation, directly control viral replication efficiency.
• Protein acylation is an emerging regulatory layer that influences viral infection outcomes by altering viral and host protein function.
• Antiviral drugs such as onradivir demonstrate that pharmacological modulation of viral process regulation is clinically actionable.
• CRISPR knockout, knock-in, and overexpression models are essential for dissecting which host genes causally regulate viral processes.
Description
The Gene Ontology term GO:0050792, regulation of viral process, defines any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts. This term captures both viral-encoded regulators, such as viral microRNAs, and host-encoded regulators, including epigenetic enzymes and RNA-modifying proteins, that collectively determine whether an infection proceeds productively or is restricted. Understanding this regulatory layer is critical because it represents the interface where host defense and viral counter-defense converge, and it is increasingly recognized as a source of therapeutic targets. For researchers, GO:0050792 provides a structured framework to annotate genes and pathways that do not directly execute viral replication steps but instead tune their efficiency. Viral miRNAs, for example, are non-coding RNAs encoded by herpesviruses, polyomaviruses, and other DNA viruses that downregulate host transcripts involved in apoptosis, antigen presentation, and cell cycle control, thereby modulating the viral life cycle. Similarly, host epitranscriptomic writers and erasers, such as METTL3 and FTO, regulate viral RNA stability and translation, directly impacting replication kinetics. This article synthesizes authoritative QuickGO annotation data with verified PubMed literature to provide a research-grade overview of GO:0050792. We cover the definition, biological significance, core molecular mechanisms, key genes, disease associations, and state-of-the-art experimental methods, including CRISPR-based models and functional genomics screens. The goal is to equip virologists, immunologists, and gene-editing scientists with a precise, citable resource for studying how viral processes are regulated.
regulation of viral process At A Glance
| GO ID | GO:0050792 |
|---|---|
| GO term | regulation of viral process |
| Ontology | biological_process |
| Synonym | regulation of viral reproduction |
| Definition | Any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts. |
| Major function | Modulation of viral replication, spread, and host-pathogen interactions |
| Related processes | Epigenetic regulation, epitranscriptomic modification, protein acylation, viral miRNA-mediated gene silencing |
| Taxonomic scope | Viruses and their hosts, including vertebrates, invertebrates, and plants |
What Is GO:0050792?
GO:0050792 regulation of viral process is a biological process ontology term defined as any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts. It encompasses both positive and negative regulation, including viral-encoded factors that enhance replication and host-encoded restriction factors that limit it. The term is a parent to more specific regulatory processes and is distinct from the execution of viral life cycle steps themselves.
Why Is regulation of viral process Important in Cell Biology?
GO:0050792 is important because it defines the regulatory layer that determines the outcome of viral infection, from asymptomatic clearance to severe disease. Viral pathogens such as influenza, HIV, and SARS-CoV-2 rely on both viral and host regulatory factors to replicate efficiently and evade immunity. Pharmacological modulation of these regulators, exemplified by the approved antiviral onradivir, validates this term as a therapeutic target space. Moreover, viral safety of biologics and gene therapy products depends on understanding how viral processes are regulated to prevent adventitious agent contamination.
• Determines viral replication efficiency and host range.
• Controls immune evasion through viral miRNA-mediated silencing of host defense genes.
• Epigenetic and epitranscriptomic modifications regulate viral RNA and DNA function.
• Protein acylation alters viral and host protein activity during infection.
• Provides targets for antiviral drug development, such as onradivir.
• Critical for viral safety in biologics and gene therapy manufacturing.
• Impacts vaccine design by revealing host factors that restrict or enhance viral spread.
• Enables functional genomics screens to identify host dependency and restriction factors.
• Links to cancer biology through oncogenic viruses that modulate host cell cycle and apoptosis.
• Informs CRISPR-based antiviral strategies targeting host regulatory genes.
What Happens During regulation of viral process?
Viral miRNA-mediated regulation of host gene expression
In simple terms: Viruses produce small RNAs that silence host genes to create a favorable environment for infection.
Many DNA viruses, including herpesviruses and polyomaviruses, encode microRNAs (miRNAs) that are processed by the host RNA interference machinery. These viral miRNAs bind partially complementary sequences in host mRNAs, leading to translational repression or degradation. By targeting host transcripts involved in apoptosis, immune signaling, and cell cycle control, viral miRNAs modulate the viral life cycle and promote persistence. This represents a direct mechanism of regulation of viral process at the post-transcriptional level.
Epigenetic and epitranscriptomic control of viral replication
In simple terms: Chemical marks on DNA, histones, and RNA can switch viral replication on or off.
Host epigenetic enzymes deposit or remove histone modifications and DNA methylation at viral promoters, thereby controlling viral gene expression. Similarly, epitranscriptomic marks such as N6-methyladenosine (m6A) on viral RNA regulate its stability, splicing, and translation. Writers, erasers, and readers of these marks act as positive or negative regulators of viral replication, and viruses often hijack these machineries to enhance their life cycle.
Protein acylation in viral infection
In simple terms: Adding fatty acid groups to proteins changes their location and function during infection.
Protein acylation, including palmitoylation and myristoylation, is a reversible lipid modification that targets proteins to membranes and regulates protein-protein interactions. Both viral and host proteins undergo acylation, which can affect viral entry, assembly, and budding. Recent studies highlight that acylation of viral glycoproteins and host signaling molecules modulates the efficiency of viral infection, making it a key regulatory mechanism within GO:0050792.
Host restriction factors and interferon-stimulated genes
In simple terms: Host cells produce defense proteins that block viral replication steps.
Interferon signaling induces hundreds of interferon-stimulated genes (ISGs), many of which directly inhibit viral life cycle steps. These restriction factors, such as IFITM proteins, APOBEC3 family members, and TRIM proteins, are negative regulators of viral process. Viruses counteract them through accessory proteins and miRNA-mediated silencing. The balance between restriction factors and viral antagonists determines infection outcome and is a central theme of GO:0050792.
Viral modulation of host cell death and survival pathways
In simple terms: Viruses manipulate the host's self-destruct switches to stay alive longer.
Apoptosis, necroptosis, and autophagy are host cell death pathways that can limit viral spread. Viruses encode regulators that inhibit or delay these pathways, while host cells activate them as a defense. Viral miRNAs and proteins target key apoptotic effectors such as caspases and BCL-2 family members. This regulation of cell death timing is a critical component of the viral life cycle and falls under GO:0050792.
Key Genes Involved in GO:0050792 regulation of viral process
The following genes and proteins are established regulators of viral processes, encompassing viral-encoded factors and host-encoded epigenetic, epitranscriptomic, and signaling modulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL3 | m6A RNA methyltransferase; deposits m6A on viral and host RNAs | Regulates viral RNA stability and translation; target for epitranscriptomic studies |
| FTO | m6A demethylase; removes m6A marks | Modulates viral replication by altering RNA modification landscape |
| ALKBH5 | m6A demethylase | Impacts viral RNA fate and innate immune sensing |
| YTHDF1/2/3 | m6A reader proteins | Mediate downstream effects of m6A on viral RNA translation and decay |
| HDAC1/2 | Histone deacetylases | Repress viral promoter activity; targets for latency-reversing agents |
| EP300 | Histone acetyltransferase | Activates viral and host gene expression; modulates infection |
| DNMT1 | DNA methyltransferase | Maintains methylation of viral genomes; regulates latency |
| TET2 | DNA demethylase | Promotes viral gene expression by removing 5mC marks |
| ZAP | Zinc finger antiviral protein | Restricts viral RNA accumulation; interferon-stimulated |
| IFITM3 | Interferon-induced transmembrane protein | Blocks viral entry; negative regulator of viral process |
| APOBEC3G | Cytidine deaminase | Restricts retroviral replication by hypermutation |
| TRIM25 | E3 ubiquitin ligase | Activates RIG-I signaling; enhances antiviral response |
| miR-UL112 | Human cytomegalovirus-encoded miRNA | Downregulates host MICB; immune evasion |
| miR-K12-11 | Kaposi's sarcoma-associated herpesvirus miRNA | Mimics host miR-155; modulates gene expression |
| miR-BARTs | Epstein-Barr virus-encoded miRNAs | Target host and viral transcripts; regulate latency |
| CueR | Copper efflux regulator in bacteria | Model for metal-responsive regulation; not directly antiviral but illustrates regulatory principles |
| Onradivir | Small-molecule antiviral (not a gene) | Approved drug targeting influenza viral process |
How Is regulation of viral process Regulated?
Regulation of viral process is itself subject to multiple layers of control. Host interferon signaling induces hundreds of ISGs that act as negative regulators, while viruses encode antagonists that counteract them. Epigenetic and epitranscriptomic enzymes are dynamically regulated by infection and can be targeted pharmacologically. Protein acylation adds another reversible switch that can be modulated by metabolic state. In addition, viral miRNAs provide a feedback mechanism to fine-tune host gene expression during infection. These regulatory circuits are attractive targets for antiviral intervention, as demonstrated by onradivir, which inhibits influenza viral replication.
regulation of viral process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| METTL3 | Viral replication enhancement; cancer | KO and overexpression in A549 cells; m6A-seq |
| IFITM3 | Influenza susceptibility | Knockout mice; point mutation knock-in |
| APOBEC3G | HIV restriction | Knockout T cells; overexpression in HEK293T |
| miR-UL112 | HCMV immune evasion | Viral miRNA knockout virus; target site knock-in |
| HDAC1 | Herpesvirus latency | CRISPR KO in latently infected cells; HDAC inhibitors |
Viral infections and antiviral therapy
Dysregulation of viral process regulation can lead to uncontrolled viral replication and severe disease. Influenza, HIV, and herpesviruses all rely on host and viral regulators to establish productive infection. Antiviral drugs such as onradivir target viral process components, and understanding host regulatory factors can reveal new therapeutic targets. Viral safety of plasma-derived products also depends on effective regulation of viral processes during manufacturing.
Viral oncogenesis
Oncogenic viruses, including Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and human papillomavirus, encode miRNAs and proteins that modulate host cell cycle, apoptosis, and immune surveillance. These viral regulators of viral process contribute to cellular transformation and tumor maintenance. Epigenetic and epitranscriptomic changes induced by these viruses further promote oncogenesis.
Gene therapy and viral vector safety
Adeno-associated virus and lentiviral vectors used in gene therapy must be carefully regulated to ensure safe and efficient gene delivery. Understanding how host factors regulate viral vector transduction and how to prevent replication-competent virus formation is critical for clinical development. Regulatory requirements for viral safety in biologics further underscore the importance of GO:0050792.
From regulation of viral process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X restrict viral replication? | CRISPR knockout in permissive cell line followed by viral infection |
| Does a specific point mutation in gene X affect antiviral activity? | Point mutation knock-in via CRISPR |
| Does overexpression of gene X enhance viral replication? | CRISPR activation or lentiviral overexpression |
| Where does protein X localize during infection? | Tagged knock-in with fluorescent protein |
| Which host genes regulate viral process in a genome-wide manner? | CRISPR library screening |
| Does viral miRNA target a specific host transcript? | Knock-in of miRNA target site mutations; reporter assays |
How to Study the regulation of viral process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Host genes affecting viral replication | Identify antiviral and proviral factors |
| m6A-seq / MeRIP-seq | m6A modification sites on RNA | Map epitranscriptomic regulation of viral RNA |
| CLIP-seq | miRNA-mRNA interactions | Identify viral miRNA targets |
| Proteomics / acylation profiling | Protein abundance and modifications | Discover acylated viral and host proteins |
| RNA-seq | Transcriptional changes during infection | Measure host and viral gene expression |
| Plaque assay | Viral titer | Quantify replication efficiency |
| Reporter assays | Promoter or 3'UTR activity | Validate regulatory elements |
| Flow cytometry | Infected cell frequency and protein expression | Assess viral spread and immune evasion |
CRISPR knockout and knock-in screens
Genome-wide CRISPR knockout screens enable unbiased identification of host genes that regulate viral replication. Cells are transduced with a lentiviral sgRNA library, selected, and infected with a virus of interest. sgRNAs that are enriched or depleted after infection reveal proviral and antiviral factors. Knock-in of specific mutations allows precise dissection of functional domains.
Epitranscriptomic profiling (m6A-seq, MeRIP-seq)
Antibody-based enrichment of m6A-modified RNA followed by sequencing maps the epitranscriptomic landscape on viral and host transcripts. This method identifies which viral RNAs are modified and how writers, erasers, and readers regulate their fate during infection.
Proteomics and acylation profiling
Mass spectrometry-based proteomics can identify acylated viral and host proteins during infection. Click chemistry or acyl-biotin exchange assays enrich acylated peptides, revealing regulatory modifications that affect viral entry, assembly, and egress.
Viral miRNA target identification
Crosslinking and immunoprecipitation (CLIP) of Argonaute proteins followed by sequencing (CLIP-seq) identifies viral miRNA target sites on host mRNAs. Reporter assays and target site mutagenesis validate direct regulation.
How CRISPR Can Be Used to Study GO:0050792 regulation of viral process
Knockout
CRISPR knockout of candidate host regulatory genes, such as METTL3 or IFITM3, followed by viral infection reveals whether the gene restricts or enhances viral replication. This approach is foundational for assigning function within GO:0050792.
Point Mutation
Point mutation knock-in allows precise testing of post-translational modification sites, catalytic residues, or miRNA target sites. For example, mutating a single m6A site in a viral RNA can determine its functional importance.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous loci enables real-time tracking of regulatory proteins during infection without overexpression artifacts. This is valuable for studying dynamic regulation of viral process.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of host restriction factors or viral regulators can test sufficiency in modulating viral replication. Overexpression of ZAP or APOBEC3G, for instance, suppresses viral replication.
How EDITGENE Supports regulation of viral process Research
Researchers studying regulation of viral process-related genes often need to determine whether a candidate gene is causally involved in modulating viral replication, immune evasion, or spread. Establishing causality requires precise genetic manipulation, and CRISPR-based models provide the gold standard for such experiments. EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of viral process research.
Frequently Asked Questions About regulation of viral process
What is GO:0050792 regulation of viral process?
GO:0050792 is a Gene Ontology biological process term defined as any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts.
What genes are involved in regulation of viral process?
Key genes include METTL3, FTO, ALKBH5, YTHDF proteins, HDAC1/2, EP300, DNMT1, TET2, ZAP, IFITM3, APOBEC3G, TRIM25, and viral miRNAs such as miR-UL112 and miR-K12-11.
How do viral miRNAs regulate viral processes?
Viral miRNAs are encoded by DNA viruses and loaded into host Argonaute complexes to silence host mRNAs involved in apoptosis, immune signaling, and cell cycle control, thereby promoting viral persistence.
What is the role of m6A modification in viral replication?
m6A is an epitranscriptomic mark deposited by METTL3 and removed by FTO/ALKBH5. It regulates viral RNA stability, splicing, and translation, directly impacting replication efficiency.
How does protein acylation regulate viral infection?
Acylation adds lipid groups to viral and host proteins, affecting membrane targeting, protein interactions, and viral entry or assembly. It is a reversible regulatory modification during infection.
What drugs target regulation of viral process?
Onradivir is an approved antiviral that targets influenza viral replication, demonstrating that pharmacological modulation of viral process regulation is clinically viable.
How can CRISPR be used to study regulation of viral process?
CRISPR knockout, knock-in, point mutation, and overexpression models allow precise manipulation of host and viral regulatory genes to test their causal role in viral replication.
What is the difference between regulation of viral process and viral process itself?
Viral process refers to the execution of life cycle steps such as entry, replication, and assembly. Regulation of viral process refers to any activity that modulates the rate or extent of those steps, including host restriction factors and viral countermeasures.
Why is viral safety important in gene therapy?
Gene therapy products must be free of replication-competent viruses. Understanding regulation of viral process helps design safety assays and manufacturing controls.
What experimental models are used to study GO:0050792?
Common models include CRISPR knockout cell lines, m6A-seq, CLIP-seq, proteomics, plaque assays, and genome-wide CRISPR screens in permissive cell lines.
Conclusion
GO:0050792 regulation of viral process is a central ontology term that captures the diverse mechanisms by which viruses and their hosts modulate the viral life cycle. From viral miRNA-mediated gene silencing to epigenetic and epitranscriptomic modifications, these regulatory layers determine infection outcomes and offer numerous targets for antiviral therapy. CRISPR-based models and functional genomics screens are indispensable for dissecting these mechanisms and translating them into clinical applications. EDITGENE provides end-to-end solutions to support this research, from custom knockout and knock-in cell lines to genome-wide library screening and bioinformatics.
References
- 1. Diggins NL et al.. 2023. Viral miRNA regulation of host gene expression.. Semin Cell Dev Biol 146:2-19 PMID: 36463091
- 2. Tsai K et al.. 2020. Epigenetic and epitranscriptomic regulation of viral replication.. Nat Rev Microbiol 18(10):559-570 PMID: 32533130
- 3. Mohammad R. 2022. Key considerations in formulation development for gene therapy products.. Drug Discov Today 27(1):292-303 PMID: 34500102
- 4. Song L et al.. 2025. The function and mechanism of protein acylation in the regulation of viral infection.. Virulence 16(1):2530171 PMID: 40673681
- 5. Lee A. 2025. Onradivir: First Approval.. Drugs 85(12):1609-1612 PMID: 40996478
- 6. Giritch A et al.. 2017. 125 years of virology and ascentof biotechnologies based on viral expression.. Tsitol Genet 51(2):19-39 PMID: 30484616
- 7. Velthove KJ et al.. 2013. Viral safety of human plasma-derived medicinal products: impact of regulation requirements.. Transfus Med Rev 27(3):179-83 PMID: 23886505
- 8. Hu Y et al.. 2024. The Copper Efflux Regulator (CueR).. Subcell Biochem 104:17-31 PMID: 38963481
